Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

Association of soluble HLA-G with acute rejection episodes and early development of bronchiolitis obliterans in lung transplantation.

White SR, Floreth T, Liao C, Bhorade SM.

PLoS One. 2014 Jul 28;9(7):e103643. doi: 10.1371/journal.pone.0103643. eCollection 2014.

2.

Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation.

Fisichella PM, Davis CS, Lowery E, Ramirez L, Gamelli RL, Kovacs EJ.

J Am Coll Surg. 2013 Jul;217(1):90-100; discussion 100-1. doi: 10.1016/j.jamcollsurg.2013.03.008. Epub 2013 Apr 28.

3.

Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant.

Riise GC, Andersson BA, Kjellström C, Martensson G, Nilsson FN, Ryd W, Scherstén H.

Eur Respir J. 1999 Nov;14(5):1123-30.

4.

Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.

Neurohr C, Huppmann P, Samweber B, Leuschner S, Zimmermann G, Leuchte H, Baumgartner R, Hatz R, Frey L, Ueberfuhr P, Bittmann I, Behr J; Munich Lung Transplant Group.

J Heart Lung Transplant. 2009 May;28(5):468-74. doi: 10.1016/j.healun.2009.01.014. Epub 2009 Mar 14.

PMID:
19416775
5.

Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.

Todd JL, Wang X, Sugimoto S, Kennedy VE, Zhang HL, Pavlisko EN, Kelly FL, Huang H, Kreisel D, Palmer SM, Gelman AE.

Am J Respir Crit Care Med. 2014 Mar 1;189(5):556-66. doi: 10.1164/rccm.201308-1481OC.

6.

Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.

Jaksch P, Taghavi S, Klepetko W, Salama M.

J Thorac Cardiovasc Surg. 2014 Jul;148(1):273-81. doi: 10.1016/j.jtcvs.2014.02.059. Epub 2014 Feb 26.

7.

Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome.

Bhorade SM, Chen H, Molinero L, Liao C, Garrity ER, Vigneswaran WT, Shilling R, Sperling A, Chong A, Alegre ML.

Transplantation. 2010 Sep 15;90(5):540-6. doi: 10.1097/TP.0b013e3181e8dabe.

8.

Bronchoalveolar lavage cell immunophenotyping facilitates diagnosis of lung allograft rejection.

Greenland JR, Jewell NP, Gottschall M, Trivedi NN, Kukreja J, Hays SR, Singer JP, Golden JA, Caughey GH.

Am J Transplant. 2014 Apr;14(4):831-40. doi: 10.1111/ajt.12630. Epub 2014 Feb 11.

9.

The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.

DerHovanessian A, Weigt SS, Palchevskiy V, Shino MY, Sayah DM, Gregson AL, Noble PW, Palmer SM, Fishbein MC, Kubak BM, Ardehali A, Ross DJ, Saggar R, Lynch JP 3rd, Elashoff RM, Belperio JA.

Am J Transplant. 2016 Feb;16(2):640-9. doi: 10.1111/ajt.13475. Epub 2015 Oct 13.

10.

Lung transplantation. Bronchiolitis obliterans syndrome.

Corris PA.

Chest Surg Clin N Am. 2003 Aug;13(3):543-57. Review.

PMID:
13678312
12.

The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation.

Krustrup D, Iversen M, Martinussen T, Schultz HH, Andersen CB.

Clin Transplant. 2015 Mar;29(3):179-84. doi: 10.1111/ctr.12502. Epub 2015 Mar 9.

PMID:
25533723
13.
14.

Clinical utility of bronchoalveolar lavage cell phenotype analyses in the postoperative monitoring of lung transplant recipients.

Reynaud-Gaubert M, Thomas P, Gregoire R, Badier M, Cau P, Sampol J, Giudicelli R, Fuentes P.

Eur J Cardiothorac Surg. 2002 Jan;21(1):60-6.

PMID:
11788258
15.

The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation.

Hardison MT, Galin FS, Calderon CE, Djekic UV, Parker SB, Wille KM, Jackson PL, Oster RA, Young KR, Blalock JE, Gaggar A.

J Immunol. 2009 Apr 1;182(7):4423-31. doi: 10.4049/jimmunol.0802457.

16.

Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study.

Brugière O, Thabut G, Krawice-Radanne I, Rizzo R, Dauriat G, Danel C, Suberbielle C, Mal H, Stern M, Schilte C, Pretolani M, Carosella ED, Rouas-Freiss N.

Am J Transplant. 2015 Feb;15(2):461-71. doi: 10.1111/ajt.12977. Epub 2014 Dec 8.

17.

Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings.

Reynaud-Gaubert M, Thomas P, Badier M, Cau P, Giudicelli R, Fuentes P.

Am J Respir Crit Care Med. 2000 Jun;161(6):1924-9.

PMID:
10852768
18.

Early plasma soluble receptor for advanced glycation end-product levels are associated with bronchiolitis obliterans syndrome.

Shah RJ, Bellamy SL, Lee JC, Cantu E, Diamond JM, Mangalmurti N, Kawut SM, Ware LB, Christie JD.

Am J Transplant. 2013 Mar;13(3):754-9. doi: 10.1111/ajt.12062. Epub 2013 Jan 17.

19.

Assessing the cells in the lung lavage: an untapped resource in lung transplant monitoring.

Neujahr DC.

Am J Transplant. 2014 Apr;14(4):748-9. doi: 10.1111/ajt.12632. Epub 2014 Jan 21. No abstract available.

20.

HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction.

Girnita AL, Duquesnoy R, Yousem SA, Iacono AT, Corcoran TE, Buzoianu M, Johnson B, Spichty KJ, Dauber JH, Burckart G, Griffith BP, McCurry KR, Zeevi A.

Am J Transplant. 2005 Jan;5(1):131-8.

Supplemental Content

Support Center